Cargando…

Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study

Multiple sclerosis is the most common chronic disabling disease in the central nervous system in young to middle aged adults. Depression is common in multiple sclerosis (MS) affecting between 50–60% of patients. Pilot studies in unipolar depression report an improvement in depression when omega-3 fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shinto, Lynne, Marracci, Gail, Mohr, David C., Bumgarner, Lauren, Murchison, Charles, Senders, Angela, Bourdette, Dennis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723316/ https://www.ncbi.nlm.nih.gov/pubmed/26799942 http://dx.doi.org/10.1371/journal.pone.0147195

Ejemplares similares

The Effects of Omega-3 Fatty Acids on Matrix Metalloproteinase-9 Production and Cell Migration in Human Immune Cells: Implications for Multiple Sclerosis
por: Shinto, Lynne, et al.
Publicado: (2011)

A Randomized Placebo-Controlled Pilot Trial of Omega-3 Fatty Acids and Alpha Lipoic Acid in Alzheimer’s Disease
por: Shinto, Lynne, et al.
Publicado: (2014)

Mind-Body Medicine for Multiple Sclerosis: A Systematic Review
por: Senders, Angela, et al.
Publicado: (2012)

Falls in People with Multiple Sclerosis Compared with Falls in Healthy Controls
por: Mazumder, Rajarshi, et al.
Publicado: (2014)

Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial
por: Falardeau, Julie, et al.
Publicado: (2019)

Mitochondrial dysfunction and neurodegeneration in multiple sclerosis
por: Su, Kimmy, et al.
Publicado: (2013)

New oral disease-modifying therapies for multiple sclerosis
por: Bagert, Bridget A, et al.
Publicado: (2009)

P02.183. Comparing the bioavailability of two forms of lipoic acid in multiple sclerosis
por: Salinthone, S, et al.
Publicado: (2012)

Recent developments in multiple sclerosis therapeutics
por: Spain, Rebecca I, et al.
Publicado: (2009)

Cases of Hereditary, Multiple, Fatty Tumours
por: Murchison, Charles
Publicado: (1857)

Lipoic Acid Pharmacokinetics at Baseline and 1 year in Secondary Progressive MS
por: Bittner, Frank, et al.
Publicado: (2017)

A group-delivered self-management program reduces spasticity in people with multiple sclerosis: A randomized, controlled pilot trial
por: Hugos, Cinda L, et al.
Publicado: (2017)

Autoantibodies and Sjogren’s Syndrome in Multiple Sclerosis, a Reappraisal
por: Solomon, Andrew J., et al.
Publicado: (2013)

Predicting Falls in People with Multiple Sclerosis: Fall History Is as Accurate as More Complex Measures
por: Cameron, Michelle H., et al.
Publicado: (2013)

Lipoic acid in secondary progressive MS: A randomized controlled pilot trial
por: Spain, Rebecca, et al.
Publicado: (2017)

The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
por: Hartung, Daniel M., et al.
Publicado: (2015)

Health Behaviors, Wellness, and Multiple Sclerosis Amid COVID-19
por: Motl, Robert, et al.
Publicado: (2020)

Gray matter blood‐brain barrier water exchange dynamics are reduced in progressive multiple sclerosis
por: Tagge, Ian J, et al.
Publicado: (2021)

The Effects of Specific Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins on Gait and Functional Capacity Parameters in Patients with Relapsing-Remitting Multiple Sclerosis
por: Aristotelous, Panayiotis, et al.
Publicado: (2021)

Emulsified omega-3 fatty-acids modulate the symptoms of depressive disorder in children and adolescents: a pilot study
por: Trebatická, Jana, et al.
Publicado: (2017)

Omega 3 Fatty Acids vs Omega 6 Fatty Acids
por: Feliu, María, et al.
Publicado: (2022)

Randomized Trial of Marine n-3 Polyunsaturated Fatty Acids for the Prevention of Cerebral Small Vessel Disease and Inflammation in Aging (PUFA Trial): Rationale, Design and Baseline Results
por: Bowman, Gene L., et al.
Publicado: (2019)

Health Information Discrepancies Between Internet Media and Scientific Papers Reporting on Omega-3 Supplement Research: Comparative Analysis
por: Nault, Daryl, et al.
Publicado: (2018)

Enlarged perivascular spaces are not associated with vascular co-morbidities, clinical outcomes, and brain volumes in people with secondary progressive multiple sclerosis
por: Wooliscroft, Lindsey, et al.
Publicado: (2020)

Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms
por: Grosso, Giuseppe, et al.
Publicado: (2014)

Omega-3 Fatty Acids Supplementation in the Treatment of Depression: An Observational Study
por: Mehdi, Seema, et al.
Publicado: (2023)

Fatigue Is Associated with Poor Sleep in People with Multiple Sclerosis and Cognitive Impairment
por: Cameron, Michelle H., et al.
Publicado: (2014)

Protocol for an exploratory, randomised, single-blind clinical trial of aerobic exercise to promote remyelination in multiple sclerosis
por: Wooliscroft, Lindsey, et al.
Publicado: (2023)

Omega-3 Fatty Acids for the Treatment of Depression: Systematic Review and Meta-Analysis
por: Bloch, Michael H., et al.
Publicado: (2011)

Perinatal depression and omega-3 fatty acids: A Mendelian randomisation study
por: Sallis, Hannah, et al.
Publicado: (2014)

The Role of Physical Exercise and Omega-3 Fatty Acids in Depressive  Illness in the Elderly
por: Farioli-Vecchioli, Stefano, et al.
Publicado: (2018)

Food for Mood: Relevance of Nutritional Omega-3 Fatty Acids for Depression and Anxiety
por: Larrieu, Thomas, et al.
Publicado: (2018)

Omega-3 fatty acids and the treatment of depression: a review of scientific evidence
por: Wani, Ab Latif, et al.
Publicado: (2015)

Food for mood: Relevance of nutritional Omega-3 fatty acids for depression and anxiety
por: Laye, S.
Publicado: (2021)

Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes in Response to Omega-3 Supplementation: A Dose-Response Pilot Study
por: Drobnic, Franchek, et al.
Publicado: (2017)

Nutrition, psychoneuroimmunology and depression: the therapeutic implications of omega-3 fatty acids in interferon-α-induced depression
por: Su, Kuan-Pin
Publicado: (2015)

Omega-3 versus Omega-6 fatty acid availability is controlled by hydrophobic site geometries of phospholipase A(2)s
por: Hayashi, Daiki, et al.
Publicado: (2021)

Imbalance between Omega-6 and Omega-3 Polyunsaturated Fatty Acids in Early Pregnancy Is Predictive of Postpartum Depression in a Belgian Cohort
por: Hoge, Axelle, et al.
Publicado: (2019)

Levels of omega-3 fatty acid in serum phospholipids and depression in patients with lung cancer
por: Kobayakawa, M, et al.
Publicado: (2005)

Omega-3 fatty acids and major depression: A primer for the mental health professional
por: Logan, Alan C
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_ebvj9f71s3jkrh8kp5sqn29vqg